About this trial
This randomized controlled trial aims to evaluate the effectiveness of a Meleis' Transition Theory-based education and counseling program on menopausal symptoms, perimenopausal depression, and menopause-specific quality of life among naturally menopausal women aged 45 to 55 years.
Participants will be randomly assigned to either the intervention group or the control group. The intervention group will receive a structured four-week education and counseling program based on Meleis' Transition Theory, supported by a secure online messaging group and follow-up counseling sessions. The control group will receive routine care and standard information during the study period and will be offered a one-day educational session after completion of the final assessment.
The outcomes will be measured at baseline and Week 16 using the Menopause Rating Scale, the Perimenopausal Depression Scale, and the Menopause-Specific Quality of Life Questionnaire-II.
Eligibility criteria
Qualifiers
Female participants aged 45 to 55 years
Naturally menopausal women
Menopause duration not exceeding 2 years
Experiencing menopausal symptoms
Disqualifiers
Failure to continue participation in the study
Failure to attend education and counseling sessions
Withdrawal from the study at any time
Withdrawal of informed consent
Trial design
Treatments tested in this trial
- Meleis' Transition Theory-Based Education and Counseling Program
- Standard Information
Treatment groups
Sponsors and collaborators
Ankara Medipol University
Lead sponsor
Gulhane School of Nursing
Collaborator